Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patients (Q33418504)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patients |
scientific article |
Statements
1 reference
Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patients (English)
1 reference
Gordon Guyatt
1 reference
Diane Heels-Ansdell
1 reference
John Muscedere
1 reference
Lauralyn McIntyre
1 reference
Canadian Critical Care Trials Group
1 reference
Deborah Cook
1 reference
Yaseen Arabi
1 reference
Michael J Jacka
1 reference
Yoanna K Skrobik
1 reference
Ismael Qushmaq
1 reference
Nicholas Vlahakis
1 reference
Sangeeta Mehta
1 reference
Jamie Cooper
1 reference
Sachin Sud
1 reference
Nicole Mittmann
1 reference
Peter Dodek
1 reference
James R Klinger
1 reference
Ian Seppelt
1 reference
Christopher James Doig
1 reference
Australia and New Zealand Intensive Care Society Clinical Trials Group
1 reference
Simon Finfer
1 reference
Robert A Fowler
1 reference
William Geerts
1 reference
Michael K Gould
1 reference
Ruxandra Pinto
1 reference
Orges Ormanidhi
1 reference
Marcelo G Rocha
1 reference
Richard Hall
1 reference
John C Marshall
1 reference
John F Cade
1 reference
1 November 2014
1 reference
1 reference
312
1 reference
20
1 reference
2135-2145
1 reference
Identifiers
1 reference
1 reference